Futures up: Dow 0.47%, S&P 0.37%, Nasdaq 0.11%.
Aug 3 (Reuters) - U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.
Shares of Dupont rose 2.5% in premarket trading after the industrial materials maker raised its full-year forecast for a second time.
Stronger-than-expected profit reports have ratcheted up already high forecasts of second-quarter results for Corporate America, with earnings now estimated to have climbed about 90% versus forecasts of 65.4% at the start of July, according to IBES data from Refinitiv.
Still, Wall Street's main indexes have slipped from record highs as investors booked profit amid lofty stock valuations and as concerns over slowing economic growth and rising cases of the Delta variant hit sentiment.
A deepening regulatory crackdown in China has also sent jitters across the global technology sector. China's Tencent Holdings Ltd slumped as much as 10% in Asia after a Chinese state media outlet branded online games as "spiritual opium".
Shares of U.S.-listed gaming companies including Activision Blizzard Inc, Take-Two Interactive Software Inc and Electronic Arts Inc inched lower by 07:08 a.m. ET.
Dow e-minis rose 0.47%, S&P500 e-minis added 0.37% and Nasdaq 100 e-minis gained 0.11%.
Bond yields steadied after weaker-than-expected manufacturing data in the previous session sent them to their lowest since July 20.
Shares of major U.S. banks, which generally track yields, also inched higher in early deals.
Focus on Tuesday will be on factory orders for June, while later in the week, traders will turn to data on the U.S. services sector and the monthly jobs report for July.
Translate Bio surged 29.5% after France's Sanofi agreed to buy the U.S. biotech company in a $3.2 billion deal.
In earnings-driven moves, Under Armour Inc jumped 4.5% after raising its annual revenue forecast, while drugmaker Eli Lilly and Co slipped 1.6% as it reported a 2% drop in quarterly profit.
(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Arun Koyyur)